Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Sees Significant Decrease in Short Interest kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Expected to Post Q4 2023 Earnings of ($0.36) Per Share theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have covered the […]
Oppenheimer assumed coverage on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research note published on Thursday, MarketBeat Ratings reports. The firm issued an outperform rating and a $13.00 price target on the stock. Separately, Raymond James cut their price objective on shares of Fusion Pharmaceuticals from $13.00 to $12.00 and set an […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $9.50 Consensus PT from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.